Launch of Invista (dasatinib) in India announced by Dr. Reddy's laboratories

▴ Launch of Invista dasatinib in India announced by Dr Reddys laboratories
It is indicated for the treatment of chronic accelerated or myeloid or lymphoid blast phase and newly diagnosed in chronic phase adult patients with Chronic Myeloid Leukemia (CML) in India

The launch of Invista, a formulation of Dasatinib was announced by Dr. Reddy’s Laboratories. It is a equivalent to the innovator brand. It is to be used for the treatment of chronic accelerated or myeloid or lymphoid blast phase and newly diagnosed in chronic phase adult patients with Chronic Myeloid Leukemia (CML) in India.
Commenting on the launch, M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories said, “We are pleased to bring this important and complex product to the market in India. The development and launch of Invista is a significant step forward in improving access to medicines at an affordable price for CML patients in India.
It is available in strengths of 50, 70 and 100 mg tablets.

Tags : #DrReddyLabs #Invista #leukemia

Related Stories

23 Jan

When a Government Hospital Became a Lifesaver: The Story of India’s First ‘Mechanical Heart’ Implant

The Army Hospital’s achievement is a shining example of how determination and skill can overcome even the most daunting challenges.

View
21 Jan

When Lifesaving Drugs Become Trash: The Scandal of Dumped Government Medicines in J&K

By addressing the root causes of inefficiency and neglect, India can build a healthcare system that truly serves its people.

View
13 Jan

The End of Healthcare Discrimination: CGHS Guidelines You Need to Know

For the millions of CGHS beneficiaries, these reforms represent improved healthcare access and a step toward dignity and fairness in medical treatment.

View
10 Dec

Rewriting Elderly Care: Rs 5 Lakh Healthcare for India’s Elderly Through Ayushman Vay Vandana Card

In a world where aging often comes with increased vulnerability, the Ayushman Vay Vandana Card stands as a ray of hope.

View
05 Dec

From Research to Reality: India’s ₹500 Crore Answer to Drug-Resistant Bacteria

As this indigenous antibiotic becomes available, it carries with it the promise of a healthier future, a future where pneumonia and other drug-resistant infections no longer claim millions of lives.

View
06 Aug

Government Initiatives Boost India’s Doctor-Population Ratio Beyond WHO Standards

While the overall doctor-population ratio is favourable, there is still a disparity in the distribution of doctors between urban and rural areas. Efforts must be made to encourage doctors to work in underserved regions and provide incentives for them to do so.

View
26 Jul

Investing in India’s Path to a Healthier and Brighter Future

By investing in the health, education, and development of adolescents, India is not only ensuring a brighter future for its youth but also paving the way for substantial economic growth.

View
06 Nov

Streamlining Bond Periods for PG Doctors: A Positive Shift in Tamil Nadu's Healthcare

By introducing flexibility and aligning the bond system with the evolving needs of the healthcare sector, the state health department aims to create a more supportive environment for doctors while ensuring the optimal functioning of government healthcare facilities.

View
13 Sep

An “Umbrella scheme” Rashtriya Arogya Nidhi (RAN): Providing Lifeline for Costly Medical Treatments

Rashtriya Arogya Nidhi (RAN) is a commendable initiative by India's Ministry of Health and Family Welfare. It aids impoverished individuals in dire need of expensive medical care. Let's support this vital cause for a healthier nation.

View
29 Aug

Goa Leads the Way: Free IVF Treatment Offers Hope to Couples

This decision by the Goa government is a positive step for couples struggling with infertility. It also helps break the stigma surrounding infertility and offers couples the help they need without feeling ashamed.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025